Haeberle, Helene
Prohaska, Stefanie
Martus, Peter
Straub, Andreas
Zarbock, Alexander
Marx, Gernot
Zago, Manola
Giera, Martin
Koeppen, Michael
Rosenberger, Peter
Funding for this research was provided by:
University Tuebingen Germany (AKF414-0-0)
Article History
Received: 23 August 2019
Accepted: 12 February 2020
First Online: 4 March 2020
Ethics approval and consent to participate
: The ThIlo trial protocol was approved by the ethics committee of the University of Tübingen, Germany (Protocol Number 899/2018AMG1) on 4 June 2019. The local ethics committee at each site will approve the study protocol (approvals already in place are shown in Additional file InternalRef removed). Any modifications to the protocol will be immediately communicated to all responsible authorities. All patients, or their legal representative, must give written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.